[ Price : $8.95]
Responding to a Trump Administration order, FDA delays the effective date until 3/21 of a recent final rule entitled Nonprescripti...[ Price : $8.95]
HHS elevates CDRH chief medical officer for in vitro diagnostics Sara Brenner to FDA acting commissioner under the Trump Administr...[ Price : $8.95]
Merck and Eisai say results from the Phase 3 LEAP-015 trial evaluating Keytruda plus Lenvima in gastroesophageal adenocarcinoma pa...[ Price : $8.95]
FDA extends its review of a Stealth BioTherapeutics NDA for elamipretide, a first-in-class mitochondria-targeted therapeutic for t...[ Price : $8.95]
FDA grants Zai Lab an orphan drug designation to ZL-1310, an antibody-drug conjugate for treating small cell lung cancer.[ Price : $8.95]
Three Ropes & Gray attorneys review major FDA-related enforcement cases in 2024 and say it is impossible to predict with certainty...[ Price : $8.95]
Two medical device stakeholders suggest ways for FDA to regulate generative AI and foundation model-enabled medical devices.[ Price : $8.95]
FDA will review a Biogen sNDA for a Spinraza higher dose regimen.